Dr. Cohen is a Professor of Cellular and Molecular Pharmacology at the University of California, San Francisco. He is also a Partner at TPG and co-head of TPG Biotechnology, a life science focused investment effort.

For the last 28 years, Dr. Cohen has been at UCSF where he has had clinical responsibilities as an internist for hospitalized patients, a consulting endocrinologist, and as the Chief of the Division of Endocrinology and Metabolism. His research interests include structure based drug design, prion diseases, computational biology and heteropolymer chemistry. Dr. Cohen has published over 200 peer reviewed articles, participated as a co-inventor on over 10 patents and has served as an editor or editorial board member of several international scientific journals.

Dr. Cohen received his BS degree in Molecular Biophysics and Biochemistry from Yale University, his DPhil in Molecular Biophysics from Oxford on a Rhodes Scholarship, his MD from Stanford and his postdoctoral training and postgraduate medical training in Internal Medicine and Endocrinology at UCSF. He is a Fellow of the American College of Physicians and the American College of Medical Informatics and a member of the American Society for Clinical Investigation and Association of American Physicians. Dr. Cohen has received several awards for his work including a Searle Scholarship, Young investigator awards from the Endocrine Society and the Western Society for Clinical Investigation, and the LVMH Science pour l’art prize (shared with Stanley Prusiner). Dr. Cohen was elected to the Institute of Medicine of the National Academy of Sciences in 2004 and the American Academy of Arts and Sciences in 2008.